©2019 SpatioEpi.com
Data for the maps were extracted from UNAIDS and publications.
Map created by CUHK SpatioEpi Group
Antiretroviral therapy (ART) can effectively suppress the viral load of people living with HIV (PLHIV) for preventing ongoing transmission, recover their immunity and extend their life expectancy. By age progression, metabolic complications among them becomes more common nowadays.
The graduated color map shows the distribution of ART coverage in 2018. Many places achieved a high ART coverage after efforts input over the years.
To understand more about metabolic complications among PLHIV, literatures cited in two review articles about the prevalence of nonalcoholic fatty liver disease (NAFLD) in PLHIV were selected, after the exclusion of study with HCV co-infection. The prevalence is presented on the map as circle of different sizes. In general, NAFLD in PLHIV ranges between 28% and 50%. By now, only a few related studies have been conducted. Because of its increasing significance, more studies are expected to be conducted in the near future.
Data for the maps were extracted from UNAIDS and publications.
抗逆轉錄病毒療法除了能有效壓制被治療感染者的愛滋病病毒(HIV)載量以防傳播病毒,還能使感染者恢復免疫力及延長壽命。隨著這些感染者年齡增長,代謝相關併發症也越來越普遍。
漸變色地圖顯示2018年抗逆轉錄病毒療法的覆蓋率的分佈。可以看到經多年各地方的努力,很多地方都能達致高治療覆蓋率。
為了解HIV感染者的代謝相關併發症,我們從兩篇評論性文獻選出HIV感染者的非酒精性脂肪肝病(NAFLD)發病率研究文獻(合併丙型肝炎研究除外),並在地圖上以圓點大小代表HIV感染者的NAFLD發病率。一般的NAFLD發病率在28%至50%之間。截至現在只有少量相關研究。基於其重要性,期望未來會有更多相關研究。
地圖資料源自聯合國愛滋病規劃署及已刊載文獻。
What is HIV/ AIDS? 什麼是人類免疫力缺乏病毒感染/愛滋病?
How does HIV spread? 如何傳播?
Vaccine? Prevention? 如何預防?
Organisations 有關機構
Further information 詳細資料